Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Effects of a comprehensive antibiotic stewardship program on antibiotic prescribing for acute respiratory infections in rural facilities: a cluster randomized trial

Abstract

Antimicrobial resistance is driven by inappropriate use of antibiotics for acute respiratory infections (ARIs), which is a major challenge in primary care in low- and middle-income countries. Here we conducted a pragmatic, cluster randomized controlled trial in 34 township hospitals in two rural counties of Guangdong, China, to evaluate whether a digitally enabled stewardship program could reduce antibiotic prescribing. The intervention combined training and guidelines for doctors; concise, evidence-based guidelines embedded in the electronic medical record with point-of-care prompts; monthly prescribing peer review feedback for doctors; and patient education delivered through a smartphone app. Control is usual care with no inputs. During the 12-month implementation period (1 March 2020 to 28 February 2021), we analyzed 97,239 eligible consultations for ARIs. The primary outcome was whether a consultation resulted in any antibiotics being prescribed. This outcome was met: antibiotics were prescribed in 26% (14,521/54,799) of intervention consultations compared to 71% (30,340/42,440) of control consultations, yielding an adjusted risk difference of –39 percentage points (95% confidence interval: –47 to –29; P < 0.001). There was no evidence of increased harm, as 30-day hospitalization rates for respiratory illness or sepsis did not differ between groups (adjusted risk difference, 0.2 percentage points; 95% confidence interval: –0.3 to 0.6). A comprehensive stewardship program can substantially reduce inappropriate antibiotic prescribing for ARIs in rural primary care facilities in China without compromising patient safety. Trial registration: ISRCTN96892547.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CONSORT trial flow diagram.
Fig. 2: Daily total number of eligible patient consultations per treatment group.
Fig. 3: Antibiotic prescribing rate by month (actual timeline) and treatment group.

Similar content being viewed by others

Data availability

Anonymized patient-level data underlying the results of this study are held at the Guangzhou Institute of Respiratory Health. Data will be made available for non-commercial research purposes to qualified investigators upon submission of a data access application, which must include a brief study protocol and a signed data use agreement compliant with China’s Public Data Safety Law. Applications should be sent to the corresponding author (N.Z., nanshan@vip.163.com) and will be reviewed by the institutional data access committee. Decisions on access will be provided within 2 months of application, as approvals are required from both the academic institute and the Shaoguan Health Bureau to ensure compliance with current legal and regulatory requirements. Approved applicants will be granted secure access to the data repository for a time-limited period.

Code availability

The statistical code used for the analyses in this study is available for non-commercial research purposes upon submission of a request to the first author (X.W., xiaolin.wei@utoronto.ca) and the chief biostatistician (J.P.H., j.p.hicks@leeds.ac.uk). Applicants must provide a brief description of the intended use and agree to a code-sharing agreement. Requests will be reviewed within 2 weeks, and approved applicants will be provided with the relevant R scripts via a secure repository.

References

  1. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990−2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).

    Article  Google Scholar 

  2. Butler, C. C. et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338, b2242 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health 109, 309–318 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sulis, G. et al. Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 17, e1003139 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kjærgaard, J. et al. Diagnosis and treatment of acute respiratory illness in children under five in primary care in low-, middle-, and high-income countries: a descriptive FRESH AIR study. PLoS ONE 14, e0221389 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Fu, M. et al. Appropriate use of antibiotics for acute respiratory infections at primary healthcare facilities in China: a nationwide cross-sectional study from 2017 to 2019. Lancet Reg. Health West. Pac. 40, 100880 (2023).

    PubMed  PubMed Central  Google Scholar 

  7. Esmaily, H. M. et al. Can rational prescribing be improved by an outcome-based educational approach? A randomized trial completed in Iran. J. Contin. Educ. Health Prof. 30, 11–18 (2010).

    Article  PubMed  Google Scholar 

  8. Francis, N. A. et al. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. BMJ 339, b2885 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Juzych, N. S., Banerjee, M., Essenmacher, L. & Lerner, S. A. Improvements in antimicrobial prescribing for treatment of upper respiratory tract infections through provider education. J. Gen. Intern. Med. 20, 901–905 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Oliveira, I. et al. Systematic review on the impact of guidelines adherence on antibiotic prescription in respiratory infections. Antibiotics (Basel) 9, 546 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shen, X. et al. A complex intervention to reduce antibiotic prescribing in rural China: a cluster randomised controlled trial. Lancet Reg. Health West. Pac. 53, 101236 (2024).

    PubMed  PubMed Central  Google Scholar 

  12. Gjelstad, S. et al. Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study). BMJ 347, f4403 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Gerber, J. S. et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 309, 2345–2352 (2013).

    Article  CAS  PubMed  Google Scholar 

  14. Wei, X. et al. Effect of a training and educational intervention for physicians and caregivers on antibiotic prescribing for upper respiratory tract infections in children at primary care facilities in rural China: a cluster-randomised controlled trial. Lancet Glob. Health 5, e1258–e1267 (2017).

    Article  PubMed  Google Scholar 

  15. Meeker, D. et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 315, 562–570 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Feldmeier, G. et al. Optimizing antibiotic prescribing for acute respiratory tract infections in german primary care: results of the regional intervention study CHANGE-3 and the nested cRCT. Antibiotics (Basel) 12, 850 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cals, J. W., Butler, C. C., Hopstaken, R. M., Hood, K. & Dinant, G. J. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 338, b1374 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Little, P. et al. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 382, 1175–1182 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  19. Do, N. T. et al. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial. Lancet Glob. Health 4, e633–e641 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  20. Onwunduba, A., Ekwunife, O. & Onyilogwu, E. Impact of point-of-care C-reactive protein testing intervention on non-prescription dispensing of antibiotics for respiratory tract infections in private community pharmacies in Nigeria: a cluster randomized controlled trial. Int. J. Infect. Dis. 127, 137–143 (2023).

    Article  CAS  PubMed  Google Scholar 

  21. Tan, R. et al. A digital health algorithm to guide antibiotic prescription in pediatric outpatient care: a cluster randomized controlled trial. Nat. Med. 30, 76–84 (2024).

    Article  CAS  PubMed  Google Scholar 

  22. Cals, J. W. et al. Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann. Fam. Med. 11, 157–164 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jenkins, T. C. et al. Effects of clinical pathways for common outpatient infections on antibiotic prescribing. Am. J. Med. 126, 327–335 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gulliford, M. C. et al. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study. Health Technol. Assess. 23, 1−70 (2019).

    Article  Google Scholar 

  25. Mann, D. et al. Impact of clinical decision support on antibiotic prescribing for acute respiratory infections: a cluster randomized implementation trial. J. Gen. Intern. Med. 35, 788–795 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Blair, P. S. et al. Multi-faceted intervention to improve management of antibiotics for children presenting to primary care with acute cough and respiratory tract infection (CHICO): efficient cluster randomised controlled trial. BMJ 381, e072488 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chang, J. et al. Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study. Lancet Infect. Dis. 19, 1345–1354 (2019).

    Article  PubMed  Google Scholar 

  28. Heddini, A., Cars, O., Qiang, S. & Tomson, G. Antibiotic resistance in China—a major future challenge. Lancet 373, 30 (2009).

    Article  PubMed  Google Scholar 

  29. Wang, X. et al. Massive misuse of antibiotics by university students in all regions of China: implications for national policy. Int. J. Antimicrob. Agents 50, 441–446 (2017).

    Article  CAS  PubMed  Google Scholar 

  30. Zhang, Z. et al. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob. Health Action 10, 1287334 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wang, J., Wang, P., Wang, X., Zheng, Y. & Xiao, Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern. Med. 174, 1914–1920 (2014).

    Article  PubMed  Google Scholar 

  32. Wei, X. et al. Understanding factors influencing antibiotic prescribing behaviour in rural China: a qualitative process evaluation of a cluster randomized controlled trial. J. Health Serv. Res. Policy 25, 94–103 (2020).

    Article  PubMed  Google Scholar 

  33. Zhuo, C. et al. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial. Trials 21, 394 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lewnard, J. A. et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lancet 403, 2439–2454 (2024).

    Article  PubMed  Google Scholar 

  35. Hallsworth, M. et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 387, 1743–1752 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  36. Gulliford, M. C. et al. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. BMJ 364, l236 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  37. Schwartz, K. L. et al. Effect of antibiotic-prescribing feedback to high-volume primary care physicians on number of antibiotic prescriptions: a randomized clinical trial. JAMA Intern. Med. 181, 1165–1173 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Hu, Y. et al. Interventions to reduce childhood antibiotic prescribing for upper respiratory infections: systematic review and meta-analysis. J. Epidemiol. Community Health 70, 1162–1170 (2016).

    Article  PubMed  Google Scholar 

  39. Tonkin-Crine, S. K. et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst. Rev. 9, CD012252 (2017).

    PubMed  PubMed Central  Google Scholar 

  40. Wei, X. et al. Long-term outcomes of an educational intervention to reduce antibiotic prescribing for childhood upper respiratory tract infections in rural China: follow-up of a cluster-randomised controlled trial. PLoS Med. 16, e1002733 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  41. National Health and Family Planning Commission of the People's Republic of China. National Antimicrobial Therapy Guidelines [in Chinese] (People's Medical Publishing House, 2017).

  42. Benson, V. S. et al. Disease burden, treatment patterns and asthma control in adult patients with asthma in China: a real-world study. J. Asthma Allergy 17, 949–964 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  43. Koch, M. et al. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China. BMC Public Health 19, 1727 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hansson, L., Hedner, T. & Dahlof, B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press. 1, 113–119 (1992).

    Article  CAS  PubMed  Google Scholar 

  45. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: WHO practical toolkit. https://www.who.int/publications/i/item/9789241515481 (World Health Organization, 2019).

  46. Respiratory tract infections (self-limiting): prescribing antibiotics. https://www.nice.org.uk/guidance/cg69 (National Institute for Health and Care Excellence, 2008).

  47. Köchling, A. et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implement. Sci. 13, 47 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  48. Steinman, M. A., Landefeld, C. S. & Gonzales, R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289, 719–725 (2003).

    Article  PubMed  Google Scholar 

  49. WHO Model List of Essential Medicines. https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists (World Health Organization, 2019).

  50. Kahan, B. C., Li, F., Copas, A. J. & Harhay, M. O. Estimands in cluster-randomized trials: choosing analyses that answer the right question. Int. J. Epidemiol. 52, 107–118 (2022).

    Article  Google Scholar 

  51. ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical-principles_en.pdf (2020).

  52. Norton, E. C., Dowd, B. E. & Maciejewski, M. L. Marginal effects-quantifying the effect of changes in risk factors in logistic regression models. JAMA 321, 1304–1305 (2019).

    Article  PubMed  Google Scholar 

  53. Ren, S. et al. Nonparametric bootstrapping for hierarchical data. J. Appl. Stat. 37, 1487–1498 (2010).

    Article  Google Scholar 

  54. Efron, B. & Tibshirani, R. J. An Introduction to the Bootstrap (Chapman & Hall/CRC, 1993).

  55. Holmberg, M. J. & Andersen, L. W. Adjustment for baseline characteristics in randomized clinical trials. JAMA 328, 2155–2156 (2022).

    Article  PubMed  Google Scholar 

  56. Malehi, A. S., Pourmotahari, F. & Angali, K. A. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ. Rev. 5, 11 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  57. Desai, M., Pieper, K. S. & Mahaffey, K. Challenges and solutions to pre- and post-randomization subgroup analyses. Curr. Cardiol. Rep. 16, 531 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Tchetgen Tchetgen, E. J., Phiri, K. & Shapiro, R. A simple regression-based approach to account for survival bias in birth outcomes research. Epidemiology 26, 473–480 (2015).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the support provided by the 36 township hospitals, including 34 in the trial and two in the pilot, in Shaoguan Prefecture, China, which were directly involved in the pilot and endline periods. We thank all patients and/or caregivers and healthcare providers who were involved in the trial. The study was funded by the China Primary Health Care Foundation (awarded to C.Z., X.W. and J.Z.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

X.W., J.P.H., C.Z., Z.Z. and N.Z. contributed to the study design. X.W., C.Z., J.D.W., Z.Z., J.Z., W.G. and H.H. contributed to guideline development, training and implementation. X.W. and J.P.H. drafted the manuscript, with support from Z.Z. and S.W., and N.Z., C.Z., F.S. and A.B. commented on the manuscript. Z.Z. prepared and cleaned the data. J.P.H. analyzed the data and provided substantial scientific input in statistical methods and interpretation of results. N.Z. is the overall lead of the research consortium. The corresponding authors attest that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Corresponding authors

Correspondence to Xiaolin Wei or Nanshan Zhong.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Medicine thanks Rainer Tan and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available. Primary Handling Editor: Ming Yang, in collaboration with the Nature Medicine team.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Endline antibiotic prescription rate per intervention-group township hospital.

Bars indicate the antibiotic prescription rate (the percentage of eligible consultations where any acute respiratory infection[s] were diagnosed that resulted in any antibiotics being prescribed) across the endline period for each township hospital in the intervention group only. The 10th percentile (18%), mean (26.5%) and 90th (35%) percentile of those values are also illustrated (interquartile range = 10.3). Township hospitals are ordered by their endline antibiotic prescription rate.

Extended Data Fig. 2 Percentage point change in antibiotic prescription rate between baseline and endline per cluster.

APR = antibiotic prescription rate. Bars and values indicate the percentage point change in the antibiotic prescription rate between the baseline period and the endline period for each cluster, where the antibiotic prescription rate is the percentage of eligible patient consultations (where an acute respiratory infection was diagnosed) that resulted in any antibiotics.

Extended Data Fig. 3 Hospitalisation rate within 30 days after an eligible patient consultation in a township hospital by month (actual timeline) and treatment group.

Diamonds/squares and values represent the percentage of eligible patient consultations (where an acute respiratory infection was diagnosed) where the patient was subsequently hospitalised in any hospital within the Shaoguan Prefecture within 30 days of that consultation for the indicated treatment group and month relative to when the intervention started being implemented. The suspended period occurred when COVID-19 pandemic restrictions closed township hospitals and the trial was suspended.

Supplementary information

Supplementary Information

CONSORT checklist, Trial protocol and Statistical analysis plan.

Reporting Summary

Peer Review File

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, X., Zhuo, C., Hicks, J.P. et al. Effects of a comprehensive antibiotic stewardship program on antibiotic prescribing for acute respiratory infections in rural facilities: a cluster randomized trial. Nat Med (2026). https://doi.org/10.1038/s41591-026-04222-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41591-026-04222-y

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing